Callisto Pharmaceuticals, Inc. (Callisto) is a biopharmaceutical company focused primarily on the development of drugs to treat neuroendocrine cancer (including advanced carcinoid cancer), acute leukemia and gastrointestinal disorders and diseases. The Company’s lead drug candidate,... more

Exelixis, Inc. is a biotechnology company engaged in the development of differentiated pharmaceutical products for the treatment of cancer and other serious diseases. Exelixis has a pipeline of compounds in various stages of development that will potentially treat cancer, renal disease... more

Array BioPharma Inc. (Array) is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs. The Company’s drug development pipeline includes clinical candidates that are designed to treat patients afflicted with cancer,... more

Telik, Inc. is a biopharmaceutical company working to discover, develop and commercialize small molecule drugs to treat diseases. The Company discovered its product candidates using its drug discovery technology, Target-Related Affinity Profiling (TRAP). As of December 31, 2007, Telik has... more

Vasogen Inc. (Vasogen) is a biotechnology company focused on the research and commercial development of therapies designed to target the destructive inflammatory process associated with the development and progression of cardiovascular and neurodegenerative disorders. The Company’s lead... more

Targeted Genetics Corporation (Targeted Genetics) is a clinical-stage biotechnology company. The Company is engaged in developing and commercializing therapeutic products called gene therapeutics. The product candidate is being developed as a treatment for inflammatory arthritis, and... more

Alkermes, Inc (Alkermes) is a biotechnology company. The Company manufactures RISPERDAL CONSTA for schizophrenia and developed and manufacture VIVITROL for alcohol dependence. Alkermes ia a long-acting formulation of risperidone, a product of Janssen Pharmaceutica, Inc., a division of... more

Inflazyme is a public company and we invite all current and prospective shareholders, partners, customers, and friends and other interested parties to browse our web site to learn more about the exciting science and opportunities at our Company.

United Therapeutics Corporation is a biotechnology company focused on the development and commercialization of products to address the medical needs of patients with chronic and cardiovascular, and infectious diseases and cancer. The Company’s principal therapeutic platforms include... more

Based in Ann Arbor, MI, Esperion was founded by a group of scientists who worked on the discovery and development of Lipitor.

At ILEX, we continue to research and acquire compounds with unique mechanisms of action, targeting novel receptors. We are focused on building a portfolio of oncology compounds that are different than those already available to patients and that provide new hope with effective and safe... more

ARIUS is a biotechnology company discovering and developing the next wave of antibody therapeutics. Established in 1999, ARIUS has built a proprietary technology platform, FunctionFIRST(TM), that rapidly identifies and selects antibodies based on their functional ability to affect... more

Rexahn Pharmaceuticals, Inc. (Rexahn) is development-stage biopharmaceutical company focused on the discovery, development, and commercialization of treatments for cancer, central nervous system (CNS) disorders, sexual dysfunction and other medical needs. Rexahn is developing targeted... more

Halozyme Therapeutics, Inc. (Halozyme) is a biopharmaceutical company developing and commercializing products targeting the extracellular matrix (Matrix) for the drug delivery, oncology, and dermatology markets. Its portfolio of products is based on the property covering the family of... more

Icagen, Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of orally administered small molecule drugs that modulate ion channel targets. The Company has identified drug candidates that modulate ion channels. Its two most advanced programs are... more

SciClone Pharmaceuticals, Inc. (SciClone ) is a biopharmaceutical company engaged in the development and commercialization of therapeutics to treat life-threatening diseases. The Company has two assets, a biotechnology business focused on developing late-stage products for cancer and... more

At ActivBiotics, we are dedicated to achieving success through leadership and the unrelenting pursuit of scientific breakthrough. Our greatest asset is our people, and we are bringing together the brightest and most talented scientific professionals to the ActivBiotics team. If you are an... more

VioQuest Pharmaceuticals, Inc. is a biopharmaceutical company focused on the acquisition, development and commercialization of clinical stage drug therapies targeting both the molecular basis of cancer and side effects of cancer treatment. The Company’s lead compound under development is... more

Locus Pharmaceuticals, Inc. is a world leader in fragment-based, computational drug design. We have combined highly integrated chemistry, crystallography and biology capabilities to create a unique drug design and development platform for oral drug therapies in areas of unmet need. All... more

Endovasc, Inc. is a business development company focused on drug development in the areas of cardiovascular and metabolic medicine. The Company’s licenses and patents describe technological advancements related to liposomes, stent coatings, and biodegradable/resorbable prostheses (stents)... more

Prana Biotechnology Limited is a development stage company at an early stage in the development of its pharmaceutical products that are designed to treat the underlying causes of degeneration of the brain and the eye as the aging process progresses. Other potential applications for the... more

Dimethaid Research Inc. is a fully integrated pharmaceutical company headquartered in Canada with subsidiaries in Europe, Asia and the Caribbean. The company is focused on the commercialization of therapeutics designed to produce minimal side effects. Dimethaid is engaged in all... more

Cortex Pharmaceuticals, Inc. (Cortex) focuses on developing small molecule compounds that positively modulate AMPA-type glutamate receptors, a complex of proteins involved in the communication between nerve cells in the mammalian brain. These compounds, termed AMPAKINE compounds, enhance... more

Alexion Pharmaceuticals, Inc. (Alexion) is a biopharmaceutical company engaged in the discovery, development and delivery of biologic therapeutic products for the treatment disease, including hematologic and neurologic diseases, cancer and autoimmune disorders. The Company has one... more

Icoria is a biotechnology company focused on the discovery, development and commercialization of diagnostics and targeted therapeutics in diabetes, obesity, oncology and other areas of unmet medical need. Our objective is to detect and treat disease earlier, preventing the onset of... more

About Genteric, Inc. Genteric is a biotech company formed to commercialize several proprietary technology platforms that harness the body's own protein production and distribution system. Using improved, non-viral and viral gene delivery techniques, Genteric's unique approach converts... more

IBEX Technologies, Inc. (IBEX) is a biopharmaceutical company engaged in the production and sale of enzymes for use as reagents in hemostasis monitoring devices, and of arthritis diagnostic kits for pharmaceutical research. It is principally engaged in the production and sale of... more

Perlegen was founded in 2001 as a spin-out from Affymetrix, a genetic tools company. For the first several years of its existence, until about 2004, Perlegen was focused on re-sequencing 50 human genomes, in order to map out the common elements of genetic diversity. During this time,... more

Velcura Therapeutics Inc. is an early-phase biotechnology company in Ann Arbor, Michigan. Our research focus is human bone homeostasis and novel therapeutics that restore bone health. Our mission is to develop highly differentiated therapies for bone disease — specifically, therapies that... more

Neurion Pharmaceuticals, Inc. is a drug development company focused on small molecule drug therapies for diseases and disorders of the central nervous system (the "CNS"). The company is actively seeking novel compounds for which there is proof-of-principle data in accepted animal model... more

Novocell, Inc. is a stem cell engineering company dedicated to creating, delivering and commercializing cell and drug therapies to treat diabetes and other chronic diseases. Novocell uses its proprietary cell encapsulation technology and expertise in cell implantation to develop a... more

Synairgen plc is the holding company for Synairgen Research Limited, a drug discovery and development company focused on developing therapies which address the causes, rather than the symptoms, of respiratory disease. As at June 30, 2008, the Company’s programmes were IFN-beta, protein,... more

FemmePharma, Inc. was formed by Gerianne Tringali-DiPiano in 1996 to target identifiable unmet needs within the women's healthcare pharmaceutical market. The Company has a number of drugs in development based on its PARDEL technology. FemmePharma, Inc. is devoted to developing safe and... more

Morria's proprietary drug technology platform is based on research originating from leading universities in Israel and the USA . The company has assembled an experienced team that shares its vision and is committed to making it a success. Morria's lead products are first-in-class... more

AutoImmune Inc. is a healthcare company. Most of its products are based upon the principles of mucosal tolerance. The Company has one product on the market as a dietary supplement and it is being sold by Colloral LLC, the Company’s joint venture with Deseret under the brand names,... more

Acucela Inc. is a clinical stage biotech company discovering new drug therapies for eye diseases. Neurodegenerative retinal diseases such as macular degeneration, Stargardt's disease, retinitis pigmentosa and glaucoma, significantly affect quality of life for over 50 million people... more

COR Therapeutics, Inc. is dedicated to the discovery, development and commercialization of novel pharmaceutical products for the treatment and prevention of severe cardiovascular diseases. COR has complementary research and development programs that seek to address critical needs in... more

MAP Pharmaceuticals, Inc., incorporated in July 2003, has several product candidates in clinical development, including Unit Dose Budesonide (UDB) for pediatric asthma and MAP0004 for migraine. The Company announced results from Phase II clinical studies of UDB and MAP0004 during the year... more

ZyStor Therapeutics, Inc. is a biotechnology company developing innovative therapeutics that will significantly improve the lives of patients who suffer from genetic disorders known as lysosomal storage diseases (LSDs). There are more than 40 known LSDs, each caused by a deficiency in a... more

The "Lay Line" is the straight line tracing the course following which a boat can fetch an upwind mark (the shortest track to reach the target). The location of lay-lines is affected not only by wind direction shifts, but by changes in wind velocity as well. Watching for wind shifts... more

Biocortech is a biopharmaceutical company committed to the discovery and development of new treatments for psychiatric disorders, including depression, bipolar disorders, schizophrenia, and cognitive deficits. We have proprietary assays and technologies to identify biomarkers and develop... more

eXegenics, Inc., is no longer actively conducting research, but has historically been engaged in the discovery and development of drugs for treatment of cancers and drug-resistant bacterial diseases.

StrataGent Life Sciences, Inc. is a specialty drug delivery company developing products for painless, needle-free administration of otherwise injectable drugs. Its products are based on its proprietary microjet technology that delivers large and small therapeutic molecules without a... more

ARCA Discovery, Inc. is focused on developing and commercializing genetically-targeted therapies for heart failure and other cardiovascular diseases. The Company's first product is bucindolol, a third generation beta-blocker and vasodilator for advanced heart failure and other... more

KNOPP NEUROSCIENCES is committed to filling unmet needs in neurological disease. Knopp is also committed to a way of doing business that emphasizes experience, innovation, and collaboration, with the goal of developing new medicines with exceptional safety and efficiency. The company has... more

Chrysalis BioTechnology, Inc. is a biopharmaceutical company developing new therapeutics to accelerate the healing of hard and soft tissue. The Company's lead product, Chrysalin®, is currently in Phase III human clinical for bone fracture healing, and Phase II trials for chronic diabetic... more

Obecure is a clinical stage, specialized pharmaceutical, company developing novel therapeutic approaches to weight management. The company was founded in 2005 by Bio-Light Life Science Investments Ltd in order to develop proprietary weight management technology and products exclusively... more

Radius is a leading company in the discovery and development of a new generation of drug therapies for osteoporosis and women's health. The company's first drug in clinical trials is designed to build new bone in patients with osteoporosis, with the goal of reducing the risk of future... more